MIAMI, Feb. 10, 2015 /PRNewswire/ -- Biorasi, a full-service CRO powered by ProAct+™, announced today the formation of an Endocrinology Division established to consolidate and expand Biorasi market leadership in running clinical trials in diabetes and women's health, amongst others. The new division will be led by Bill Doyle, the Division Manager, out of the Miami, FL Headquarters.
Logo - http://photos.prnewswire.com/prnh/20150209/174306LOGO
"We are pleased to culminate our decade long leadership in women's health and diabetes clinical development with the formation of our Endocrinology Division," said Dr. Boris Reznik, Chairman of Biorasi. "Our global team of industry experts powered by ProAct+™ delivers Clinical Research Optimized™ to leading pharmaceutical, biotech and medical device companies; we look forward to expanding our business with current and prospective customers."
"Our explosive growth in men's and women's health, as well as in diabetes and other endocrinology indications has driven the decision to carve out a dedicated division," says Bill Doyle, Endocrinology Division Manager. "Just in the last six weeks, three major endocrinology milestones achieved include: A program we managed gained FDA approval of the Estradiol Transdermal System USP, also, we submitted the final study report for a novel Type II Diabetes therapy and we locked the database for a pivotal study in hormone replacement therapy for postmenopausal women."
About Biorasi
Biorasi is an award-winning Clinical Research Optimized™ CRO. From study design to execution success, optimization is engrained in ProAct+™ the most robust and innovative operating platform in the industry. Equipped with ProAct+, Biorasi's full service project teams have developed numerous drugs, biologics and devices that received FDA and multi-venue approvals. Biorasi is headquartered in Miami, FL and has regional offices and operations across North America and around the world.
For more information: Biorasi Contact Form
Contact: Karen Bertoli Chief Marketing Officer Email +1 (305) 216 4190
SOURCE Biorasi
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article